Related Experiment Video
Updated: Oct 19, 2025

Induction of Graft-versus-host Disease and In Vivo T Cell Monitoring Using an MHC-matched Murine Model
Published on: August 29, 2012
Keeping an 'eye' on ocular GVHD
Jelena Marie Kezic1, Steven Wiffen2, Mariapia Degli-Esposti3
1Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia.
Ocular graft-versus-host disease (GVHD) affects many patients after stem cell transplants, causing dry eye and other vision issues. Early screening and new diagnostic tools can improve detection and management of this complication.
Area of Science:
- Ophthalmology
- Hematology
- Immunology
Background:
- Ocular graft-versus-host disease (GVHD) is a frequent complication following allogeneic haematopoietic stem cell transplantation (allo-HSCT).
- It affects a significant percentage of patients, particularly those with chronic GVHD, manifesting primarily as dry eye disease and ocular surface inflammation.
- Posterior segment involvement, though less common, can include retinopathy and scleritis.
Purpose of the Study:
- To review the clinical features, diagnostic criteria, and management strategies for ocular GVHD.
- To explore potential ophthalmic screening tools for early detection and intervention.
- To describe ocular GVHD in preclinical mouse models.
Main Methods:
- Literature review of clinical features, diagnostics, and treatments for ocular GVHD.
- Discussion of current and emerging screening methods, including corneal endothelial cell density and tear biomarker analysis.
- Summary of histopathological findings from preclinical mouse models.
Main Results:
- Ocular GVHD presents with diverse symptoms, predominantly dry eye, impacting quality of life.
- Early and consistent ocular assessment, including pre-transplant screening, is crucial for timely intervention.
- Advanced screening techniques show promise for improved detection.
Conclusions:
- Regular ocular assessments and novel screening tools are vital for managing ocular GVHD post-allo-HSCT.
- Early detection and intervention can prevent severe visual impairment and improve patient well-being.
- Preclinical models offer insights into the pathogenesis and potential therapeutic targets.
More Related Videos
08:05Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
06:06Induction and Scoring of Graft-Versus-Host Disease in a Xenogeneic Murine Model and Quantification of Human T Cells in Mouse Tissues using Digital PCR
Published on: May 23, 2019
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Glaucoma: Overview
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Angle Closure Glaucoma: Treatment
Kidney Transplant I: Introduction
Cell-mediated Immune Responses